Certified by Founder Lodge
Aspen Neuroscience, Inc.
United States - La Jolla, CA
START UP
1 Disclosed Funding Rounds $147,500,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms o
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 09 ,2022 | Series B | $147,500,000 | |
| November, 21 ,2025 | Series C | $115,000,000 |
Lifeforce Capital
EDBI Pte Ltd
LYFE Capital
Revelation Partners
Newton Investment Management Group
Medical Excellence Capital, LLC
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
AIRRIVED | $6,100,000 | (Feb 4, 2026)
Derapi | $7,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
